Get started
Author

Qingmei Ye

Observed names: Qing-Mei Ye, Ye, Qing-Mei, Ye, Qingmei
Observed institutions: Hainan Normal University, Jinan University, Texas A&M University – Kingsville, Bristol-Myers Squibb (United States), Hainan General Hospital, Hainan Medical University, Texas A&M University
ORCID: 0000-0003-2237-8808
Observed ORCID: 0000-0003-2237-8808
OpenAlex ID: A5074168507
TCFH–NMI: Direct Access to N -Acyl Imidazoliums for Challenging Amide Bond Formations
2018 · Gregory L. Beutner, Ian S. Young, et al. · Organic Letters · 168
Reversal of Multidrug Resistance in Cancer by Multi-Functional Flavonoids
2019 · Qingmei Ye, Kai Liu, et al. · Frontiers in Oncology · 158
PDF
Surfactant-Mediated Dissolution of Metformin Hydrochloride Tablets: Wetting Effects Versus Ion Pairs Diffusivity
2014 · Divyakant Desai, Benjamin Wong, et al. · Journal of Pharmaceutical Sciences · 75
Orevactaene,1 a novel binding inhibitor of HIV-1 rev protein to Rev response element (RRE) from Epicoccum nigrum WC47880
1997 · Yue-Zhong Shu, Qingmei Ye, et al. · Bioorganic & Medicinal Chemistry Letters · 50
Isolation, chemotaxonomic significance and cytotoxic effects of quassinoids from Brucea javanica
2015 · Qing-Mei Ye, Liang-Liang Bai, et al. · Fitoterapia · 39
A Mini-Review of Flavone Isomers Apigenin and Genistein in Prostate Cancer Treatment
2022 · Xiaozhen Ji, Kai Liu, et al. · Frontiers in Pharmacology · 30
PDF
Improving the efficiency of quantitative 1H NMR: An innovative external standard–internal reference approach
2013 · Yande Huang, Bao-Ning Su, et al. · Journal of Pharmaceutical and Biomedical Analysis · 28
Targeting the inhibitors of apoptosis proteins (IAPs) to combat drug resistance in cancers
2025 · Qingmei Ye, Xiao-Zhao Zhuang, et al. · Frontiers in Pharmacology · 24
Bripiodionen, a New Inhibitor of Human Cytomegalovirus Protease from Streptomyces sp. WC76599
1997 · Yue-Zhong Shu, Qingmei Ye, et al. · Journal of Natural Products · 19
Role of Self-Association and Supersaturation in Oral Absorption of a Poorly Soluble Weakly Basic Drug
2015 · Ajit S. Narang, Sherif Badawy, et al. · Pharmaceutical Research · 17
An overview of the past decade of bufalin in the treatment of refractory and drug-resistant cancers: current status, challenges, and future perspectives
2023 · Qingmei Ye, Xin Zhou, et al. · Frontiers in Pharmacology · 16
PDF
The lactate metabolism and protein lactylation in epilepsy
2025 · Xi Kuang, Shuang Chen, et al. · Frontiers in Cellular Neuroscience · 14
PDF
An efficient electrophilic N-amination utilizing in situ generated chloramine under phase transfer conditions
2006 · Apurba Bhattacharya, Nitin C. Patel, et al. · Tetrahedron Letters · 14
Probing the stereoselectivity of OleD-catalyzed glycosylation of cardiotonic steroids
2018 · Xue-Lin Zhu, Chao Wen, et al. · RSC Advances · 12
PDF
Wetting Effects Versus Ion Pairs Diffusivity: Interactions of Anionic Surfactants with Highly Soluble Cationic Drugs and Its Impact on Tablet Dissolution
2015 · Divyakant Desai, Benjamin Wong, et al. · Journal of Pharmaceutical Sciences · 11
Toad venom-derived bufadienolides and their therapeutic application in prostate cancers: Current status and future directions
2023 · Qingmei Ye, Xin Zhou, et al. · Frontiers in Chemistry · 10
PDF
Oxidative degradation pathways of beclabuvir hydrochloride mediated by hydrogen peroxide and UV/Vis light
2019 · Qingmei Ye, Yande Huang, et al. · Journal of Pharmaceutical and Biomedical Analysis · 10
Identification of Critical Process Impurities and Their Impact on Process Research and Development
2008 · Yande Huang, Qingmei Ye, et al. · Organic Process Research & Development · 10
An Efficient Strategy for the Glycosylation of Total Bufadienolides in Venenum Bufonis
2019 · Zhi-Hao Fu, Chao Wen, et al. · ACS Omega · 9
Overcoming NMR line broadening of nitrogen containing compounds: A simple solution
2024 · Junhe Ma, Qingmei Ye, et al. · Magnetic Resonance in Chemistry · 8
Structural characterization of low level degradants in aztreonam injection and an innovative approach to aid HPLC method validation
2016 · Qingmei Ye, Wei Ding, et al. · Journal of Pharmaceutical and Biomedical Analysis · 8
Understanding and Controlling the Formation of an Impurity during the Development of Muraglitazar, a PPAR Dual Agonist
2009 · Qingmei Ye, Yande Huang, et al. · Organic Process Research & Development · 8
The Role of Histone Deacetylases in NLRP3 Inflammasomesmediated Epilepsy
2023 · Xi Kuang, Shuang Chen, et al. · Current Molecular Medicine · 7
Tracking the Isotopologues: Process Improvement for the Synthesis of a Deuterated Pyrazole
2023 · Zachary J. Garlets, Elizabeth M. Yuill, et al. · Organic Process Research & Development · 7
Isolation, Identification and Chemical Modification of Bufadienolides from Bufo melanostictus Schneider and Their Cytotoxic Activities against Prostate Cancer Cells
2024 · Qingmei Ye, Rong Lin, et al. · Molecules · 6
PDF
Works count: 36
Citation count: 780
H-index: 13
I10-index: 18
Year
Topic
Type